Iceland· IS-EU/1/25/1928/001-002
Aqneursa
A levacetylleucine product containing levacetylleucine, registered in Iceland by Intrabio Ireland Limited. The same ATC class is registered in 7 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Levacetylleucine is registered in 7 of 19 countries.
Countries holding a registration under ATC N07XX27 (levacetylleucine), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 5 of them publish a price we can compare per daily dose
Levacetylleucine · ATC N07XX27
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Levacetylleucine
- Manufacturer
- Intrabio Ireland Limited
- Country
- Iceland (IS)
- ATC code
- N07XX27
- ATC class
- Levacetylleucine
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Levacetylleucine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAQNEURSAIntraBio Ireland Ltd., Dublin 2
- BelgiumAqneursa 1 gIntraBio Ireland Limited
- IrelandAqneursa 1 g granules for oral suspension in sachetIntrabio Ireland Limited
- NetherlandsAqneursa 1 g granulaat voor orale suspensie in sachetIntrabio Ireland Limited
- SwedenAqneursa 1 g Granulat till oral lösning i dospåseIntrabio Ireland Limited
- United StatesAQNEURSAIntraBio Inc
- PolandAqneursaIntraBio Ireland Limited
- FinlandAqneursaIntrabio Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Aqneursa
- Norway · Aqneursa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/93d10a96-78ee-4aba-9c88-6cb779247938 GET /v1/drugs/93d10a96-78ee-4aba-9c88-6cb779247938?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Mixtúrukyrni, lausn í skammtapoka",
"source": "lyfjastofnun",
"atc_raw": "N07XX27",
"marketed": false,
"strength": "1 g",
"ma_number": "EU/1/25/1928/001-002",
"substance": "Levacetylleucine",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "46041"
}See everything about levacetylleucine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.